Neurometrix Inc (NURO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24 | -12,859 | -14,913 | -9,187 | -7,766 |
| Depreciation Amortization | 170 | 262 | 251 | 223 | 145 |
| Accounts receivable | 1,320 | -311 | 69 | -226 | -189 |
| Accounts payable and accrued liabilities | 572 | -8 | -268 | 479 | 200 |
| Other Working Capital | 2,222 | -57 | -368 | -354 | 652 |
| Other Operating Activity | -1,446 | 320 | 148 | -4,035 | -720 |
| Operating Cash Flow | $2,862 | $-12,652 | $-15,080 | $-13,100 | $-7,679 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144 | -163 | -101 | -595 | -227 |
| Investing Cash Flow | $-144 | $-163 | $-101 | $-595 | $-227 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19 | N/A | 6,667 | 20,142 | 7,932 |
| Other Financing Activity | 0 | 12,910 | 0 | -3,206 | 0 |
| Financing Cash Flow | $19 | $12,910 | $6,667 | $16,935 | $7,932 |
| Beginning Cash Position | 4,044 | 3,949 | 12,463 | 9,222 | 9,196 |
| End Cash Position | 6,780 | 4,044 | 3,949 | 12,463 | 9,222 |
| Net Cash Flow | $2,737 | $95 | $-8,514 | $3,241 | $26 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,862 | -12,652 | -15,080 | -13,100 | -7,679 |
| Capital Expenditure | -144 | -163 | -101 | -595 | -227 |
| Free Cash Flow | 2,718 | -12,816 | -15,181 | -13,695 | -7,906 |